INVESCO NASDAQ BIOTECH UCITS ETF

Benchmark

The NASDAQ Biotechnology Index contains securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.

PERFORMANCE

YTD7D30D1Y3Y5Y

Powered by

RELATED ARTICLES

Analysis

What are biotech ETFs? Investing in innovative healthcare technology

The benefits and risks of investing in these ETFs

Kent Thune

27 Sep 2023

Analysis

Citi: Concentrated thematic ETF ownership can impact liquidity

ETFs collectively own over 20% of some small cap companies as a result of rising demand for thematic strategies

Tom Eckett

09 Feb 2021